ImmunityBio (IBRX) Assets (2014 - 2026)
ImmunityBio's Assets was $628.5 million in Q2 2026, up 56.3% from $402.08 million a year earlier but down 2.8% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Assets at ImmunityBio came in at $501.9 million, up 31.1% from FY2024.
- Assets shows a five-year compound annual growth rate of 17.8% (FY2020 to FY2025).
- In earlier years, Assets was $382.93 million in FY2024 (-24.1%), $504.45 million in FY2023 (+39.2%), $362.36 million in FY2022 (-22.7%) and $468.91 million in FY2021 (+111.8%).
- Quarterly Assets has moved between $214.42 million (Q3 2021) and $646.64 million (Q1 2026) over five years.
- Compared with a year earlier, Assets has increased for four straight quarters, with growth averaging 21.1% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q1 2026 (growth of 112.9%); the worst was Q1 2025 (a decline of 24.2%).
- Per Business Quant data, IBRX's Assets in the three quarters before Q2 2026 was $646.64 million (Q1 2026), $501.9 million (Q4 2025) and $518.99 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 201.13 Bn |
| 10 | ImmunityBio | 8.65 Bn | 7.41 Bn | 50.94 Mn | 628.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 628.50 Mn |
| Mar 31, 2026 | 646.64 Mn |
| Dec 31, 2025 | 501.90 Mn |
| Sep 30, 2025 | 518.99 Mn |
| Jun 30, 2025 | 402.08 Mn |
| Mar 31, 2025 | 303.76 Mn |
| Dec 31, 2024 | 382.93 Mn |
| Sep 30, 2024 | 364.57 Mn |
| Jun 30, 2024 | 444.33 Mn |
| Mar 31, 2024 | 400.68 Mn |
| Dec 31, 2023 | 504.45 Mn |
| Sep 30, 2023 | 432.42 Mn |
| Jun 30, 2023 | 291.23 Mn |
| Mar 31, 2023 | 343.40 Mn |
| Dec 31, 2022 | 362.36 Mn |
| Sep 30, 2022 | 352.94 Mn |
| Jun 30, 2022 | 317.72 Mn |
| Mar 31, 2022 | 389.59 Mn |
| Dec 31, 2021 | 468.91 Mn |
| Sep 30, 2021 | 214.42 Mn |
API Access
ImmunityBio Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();